AT426617T - Therapeutic and diagnostic anti-hsp 70 antibire - Google Patents

Therapeutic and diagnostic anti-hsp 70 antibire

Info

Publication number
AT426617T
AT426617T AT04803556T AT04803556T AT426617T AT 426617 T AT426617 T AT 426617T AT 04803556 T AT04803556 T AT 04803556T AT 04803556 T AT04803556 T AT 04803556T AT 426617 T AT426617 T AT 426617T
Authority
AT
Austria
Prior art keywords
antibire
hsp
therapeutic
diagnostic anti
diagnostic
Prior art date
Application number
AT04803556T
Other languages
German (de)
Inventor
Gabriele Multhoff
Original Assignee
Multimmune Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to EP03028144 priority Critical
Application filed by Multimmune Gmbh filed Critical Multimmune Gmbh
Publication of AT426617T publication Critical patent/AT426617T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34639281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT426617(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
AT04803556T 2003-12-05 2004-12-06 Therapeutic and diagnostic anti-hsp 70 antibire AT426617T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP03028144 2003-12-05

Publications (1)

Publication Number Publication Date
AT426617T true AT426617T (en) 2009-04-15

Family

ID=34639281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803556T AT426617T (en) 2003-12-05 2004-12-06 Therapeutic and diagnostic anti-hsp 70 antibire

Country Status (8)

Country Link
US (3) US7700737B2 (en)
EP (2) EP1706423B8 (en)
JP (2) JP4898452B2 (en)
AT (1) AT426617T (en)
CY (2) CY1109125T1 (en)
DE (1) DE602004020266D1 (en)
ES (2) ES2324538T3 (en)
WO (1) WO2005054295A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054295A2 (en) * 2003-12-05 2005-06-16 Multimmune Gmbh Therapeutic and diagnostic anti-hsp 70 antibodies
CA2626238C (en) 2005-10-17 2015-10-06 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
ES2555908T3 (en) 2008-06-26 2016-01-11 Orphazyme Aps Use of Hsp70 as a regulator of enzymatic activity
EP2580232A1 (en) * 2010-06-08 2013-04-17 National University of Ireland, Galway Manipulation of hsp70 and ire1alpha protein interactions
AU2011335545A1 (en) 2010-11-30 2013-06-13 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
CN108676069A (en) 2012-01-13 2018-10-19 纪念斯隆凯特林癌症中心 Immunogenicity WT-1 peptides and its application method
US9919037B2 (en) 2013-01-15 2018-03-20 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
EP3250605A1 (en) 2015-01-26 2017-12-06 Cellectis Anti-hsp70 specific chimeric antigen receptors (cars) for cancer immunotherapy
EP3250930A1 (en) 2015-01-27 2017-12-06 Klinikum rechts der Isar der Technischen Universität München Quantitative assay for heat shock protein 70 (hsp70) protein in body fluids
WO2019043170A1 (en) 2017-08-31 2019-03-07 Multimmune Gmbh Hsp70 based combination therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
AU612370B2 (en) 1987-05-21 1991-07-11 Micromet Ag Targeted multifunctional proteins
JPH02503867A (en) 1988-04-15 1990-11-15
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
CA2140638C (en) 1992-07-24 2010-05-04 Raju Kucherlapati Generation of xenogeneic antibodies
DE69133566T2 (en) 1990-01-12 2007-12-06 Amgen Fremont Inc. Formation of xenogenic antibodies
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
GB9020282D0 (en) 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
EP0903408A3 (en) 1992-08-21 2005-11-02 Biogen, Inc. Tat-derived transport polypeptide
US5837242A (en) 1992-12-04 1998-11-17 Medical Research Council Multivalent and multispecific binding proteins, their manufacture and use
US5910488A (en) 1993-06-07 1999-06-08 Vical Incorporated Plasmids suitable for gene therapy
EP1709970A1 (en) 1995-04-27 2006-10-11 Abgenix, Inc. Human antibodies against EGFR, derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
JPH11509088A (en) 1995-06-23 1999-08-17 プレジデント アンド フェローズ オブ ハーバード カレッジ Transcriptional regulation of the gene encoding vascular endothelial growth factor receptor
WO1997014719A1 (en) 1995-10-16 1997-04-24 Unilever N.V. A bifunctional or bivalent antibody fragment analogue
AT473242T (en) 1998-05-20 2010-07-15 Immunomedics Inc Therapeutic agents containing a specific anti-hla class ii invariant chain x anti-pathogic antibodies
US20040180046A1 (en) 2000-04-26 2004-09-16 Jeff Himawan Bispecific molecules and uses thereof
DE60138558D1 (en) * 2000-09-13 2009-06-10 Multimmune Gmbh Hsp70 peptide which paces nk cell activity and its use
WO2003086383A1 (en) * 2002-04-12 2003-10-23 Multimmune Gmbh Non-toxic amounts of protein-aggregating substances stimulate hsp70 expression and function as anti-tumor agents
EP1695093A1 (en) 2003-12-05 2006-08-30 multimmune GmbH Compositions and methods for the treatment and diagnosis of neoplastic and infectious diseases
WO2005054295A2 (en) * 2003-12-05 2005-06-16 Multimmune Gmbh Therapeutic and diagnostic anti-hsp 70 antibodies

Also Published As

Publication number Publication date
WO2005054295A3 (en) 2006-12-28
EP2070947A1 (en) 2009-06-17
EP1706423B1 (en) 2009-03-25
JP5414750B2 (en) 2014-02-12
US7700737B2 (en) 2010-04-20
JP2008502314A (en) 2008-01-31
ES2484340T3 (en) 2014-08-11
EP1706423A2 (en) 2006-10-04
JP4898452B2 (en) 2012-03-14
US20120087931A1 (en) 2012-04-12
US8440188B2 (en) 2013-05-14
ES2324538T3 (en) 2009-08-10
DE602004020266D1 (en) 2009-05-07
US20100143356A1 (en) 2010-06-10
WO2005054295A8 (en) 2005-08-18
WO2005054295A2 (en) 2005-06-16
EP1706423B8 (en) 2009-07-08
CY1109125T1 (en) 2014-07-02
US20070231337A1 (en) 2007-10-04
JP2012006933A (en) 2012-01-12
EP2070947B1 (en) 2014-06-11
CY1116052T1 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
DK1505913T3 (en) Transoral endoscopic gastroosofaeagel contraventile reconstruction device
DK1644021T3 (en) Methods and compositions for the treatment of gastrointestinal diseases
DE50211581D1 (en) Surfactant-free cosmetic, dermatological and pharmaceutical agents
DE60328797D1 (en) Blood treatment device
DE60326894D1 (en) 1,4-Diazabicycloalkane derivatives, their preparation and use
DE60235204D1 (en) Medical line and line connection system
DE60226704D1 (en) Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl-amine and their pharmaceutical use
DE60327745D1 (en) Use of adapals for the treatment of dermatological illnesses
DE60333776D1 (en) Pharmaceutical and cosmetic preparations
DK1539231T3 (en) Iscom preparation and use thereof
DE60330689D1 (en) Polyetherpolyamine agents and mixtures thereof
DE60333495D1 (en) Wound and skin care compositions
DK1334091T3 (en) Thioflavin derivatives and their use in the diagnosis and therapy of Alzheimer's disease
DK1482851T3 (en) Catheter and conduit for intracerebral use
DK1513873T3 (en) Therapeutic epitopes and applications thereof
DK1370128T3 (en) Combined baler and baler
DK1545613T3 (en) Auristatin conjugates and their use in the treatment of cancer, an autoimmune disease or an infectious disease
DE60235114D1 (en) Pyrazolamides for use in the treatment of pain
DE60224846D1 (en) Diagnosis and / or analysis system at the treatment place
DK1409544T3 (en) Human DR4 antibodies and uses thereof
EG25613A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
DK1672368T3 (en) Diagnostic and therapeutic epitope
DE602004030449D1 (en) In vivo joint implant-cycle counter
IL162483D0 (en) Hyperthermia treatment and probe therefor
AT442807T (en) Patient monitor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1706423

Country of ref document: EP